ArticleFrontiers in oncology2023

The role of daratumumab in relapsed/refractory CD38 positive acute leukemias-case report on three cases with a literature review.

Witold Prejzner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.